Roman Sosnowski
Overview
Explore the profile of Roman Sosnowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wnetrzak I, Didkowska J, Sosnowski R, Czajkowski M, Sigorski D, Malkiewicz B, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858098
Despite advances in prophylaxis, early diagnosis, and treatment, urogenital cancers represent a significant challenge to public health in Poland due to their relatively high prevalence and mortality rates. This narrative...
2.
Czajkowski M, Malkiewicz B, Czajkowska K, Wierzbicki P, Poterek A, Sosnowski R, et al.
Minerva Urol Nephrol
. 2024 Nov;
PMID: 39570330
Background: Penile cancer is a relatively rare neoplasm in developed countries, with the majority of newly diagnosed cases presenting as organ-confined, with a 5-year survival rate of 90%. Therefore, it...
3.
Wnetrzak I, Czajkowski M, Baranska K, Miklewska M, Wojciechowska U, Sosnowski R, et al.
Cancer Med
. 2024 Aug;
13(16):e70092.
PMID: 39164960
Objectives: To examine the epidemiology of penile cancer in Poland compared to other European countries. Materials And Methods: Incidence and mortality data were acquired from the national cancer registries in...
4.
Kozikowski M, Zagrodzka M, Zawadzki M, Zugaj P, Osiecki R, Rzymkowski F, et al.
World J Urol
. 2024 Jul;
42(1):438.
PMID: 39046595
Purpose: Our purpose was to evaluate the prognostic value of Vesical Imaging Reporting and Data System (VI-RADS) in bladder cancer (BCa) staging and predicting recurrence or progression. Methods: We retrospectively...
5.
Sosnowski R, Rajwa P, Kamecki H
Cent European J Urol
. 2023 Dec;
76(3):180-181.
PMID: 38045780
No abstract available.
6.
Kamecki H, Mielczarek L, Szemplinski S, Debowska M, Rajwa P, Baboudjian M, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001723
Background: Data on Gleason pattern 4 (GP4) amount in biopsy tissue is important for prostate cancer (PC) risk assessment. We aim to investigate which GP4 quantification method predicts adverse pathology...
7.
Czajkowski M, Wierzbicki P, Kotulak-Chrzaszcz A, Malkiewicz B, Sosnowski R, Kmiec Z, et al.
Medicina (Kaunas)
. 2023 Sep;
59(9).
PMID: 37763742
Penile cancer is a rare neoplasm in developed countries with an incidence of 0.8/100,000 per male inhabitant. Despite the development of personalized medicine and multimodal treatment, the outcome of penile...
8.
Oprea-Lager D, MacLennan S, Bjartell A, Briganti A, Burger I, de Jong I, et al.
Eur Urol
. 2023 Sep;
85(1):49-60.
PMID: 37743194
Background: In prostate cancer (PCa), questions remain on indications for prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging and PSMA radioligand therapy, integration of advanced imaging in nomogram-based decision-making,...
9.
Szemplinski S, Kamecki H, Mokrzys M, Zawadzki M, Zagozdzon B, Debowska M, et al.
Transl Androl Urol
. 2023 Sep;
12(8):1250-1258.
PMID: 37680225
Background: Biopsy by transperineal (TP) approach is recommended standard for prostate cancer (PC) diagnosis. To avoid pain, patients undergoing TP biopsy may be offered sedation or general anesthesia. Our aim...
10.
Kielb P, Kowalczyk K, Gurwin A, Nowak L, Krajewski W, Sosnowski R, et al.
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371647
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the significant progress in cancer diagnosis and treatment over the last few years, the approach to disease...